showed a trendp = 0.04
Among patients with SVZ-contacting tumors, a higher ipsilateral SVZ dose (≥52.14 Gy) showed a trend toward improved OS (p = 0.04).
Among patients with SVZ-contacting tumors, a higher ipsilateral SVZ dose (≥52.14 Gy) showed a trend toward improved OS (p = 0.04).
Tumor location influenced PFS, with frontal, parietal, and occipital tumors showing higher PFS rates compared with temporal, thalamic, and suprasellar tumors; however, this difference did not reach statistical significance.